Paradigm Biopharmaceuticals Limited (PAR.AX)
AUD 0.32
(3.23%)
AUD 0.32
(3.23%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 56.81 Thousand AUD | 145.19% |
| 2023 | -125.72 Thousand AUD | 51.23% |
| 2022 | -257.77 Thousand AUD | 10.69% |
| 2021 | -288.64 Thousand AUD | -35.44% |
| 2020 | -213.11 Thousand AUD | -107.16% |
| 2019 | 2.97 Million AUD | 11.56% |
| 2018 | 2.66 Million AUD | 47.63% |
| 2017 | 1.8 Million AUD | 40.26% |
| 2016 | 1.28 Million AUD | 0.0% |
| 2015 | - AUD | 0.0% |
| 2014 | - AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -73.39 Thousand AUD | 0.0% |
| 2024 Q4 | 56.81 Thousand AUD | 0.0% |
| 2024 FY | -89.92 Thousand AUD | 28.47% |
| 2023 Q4 | -46.17 Thousand AUD | 0.0% |
| 2023 Q2 | -79.55 Thousand AUD | 0.0% |
| 2023 FY | -125.72 Thousand AUD | 51.23% |
| 2022 Q4 | -135.46 Thousand AUD | 0.0% |
| 2022 FY | -257.77 Thousand AUD | 10.69% |
| 2022 Q2 | -122.31 Thousand AUD | 0.0% |
| 2021 FY | -288.64 Thousand AUD | -35.44% |
| 2021 Q4 | -185.46 Thousand AUD | 0.0% |
| 2021 Q2 | -103.18 Thousand AUD | 0.0% |
| 2020 Q4 | -825.95 Thousand AUD | 0.0% |
| 2020 Q2 | 825.95 Thousand AUD | 0.0% |
| 2020 FY | -213.11 Thousand AUD | -107.16% |
| 2019 Q2 | 28.14 Thousand AUD | 0.0% |
| 2019 FY | 2.97 Million AUD | 11.56% |
| 2019 Q4 | 2.95 Million AUD | 0.0% |
| 2018 Q2 | 22.33 Thousand AUD | 0.0% |
| 2018 Q4 | 2.66 Million AUD | 0.0% |
| 2018 FY | 2.66 Million AUD | 47.63% |
| 2017 Q2 | 57.61 Thousand AUD | 0.0% |
| 2017 FY | 1.8 Million AUD | 40.26% |
| 2017 Q4 | 1.76 Million AUD | 0.0% |
| 2016 Q4 | 1.24 Million AUD | 0.0% |
| 2016 FY | 1.28 Million AUD | 0.0% |
| 2016 Q2 | 46.09 Thousand AUD | 0.0% |
| 2015 Q3 | - AUD | 0.0% |
| 2015 Q4 | - AUD | 0.0% |
| 2015 FY | - AUD | 0.0% |
| 2015 Q2 | - AUD | 0.0% |
| 2014 FY | - AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AdAlta Limited | 1.5 Million AUD | 96.232% |
| Acrux Limited | -1.28 Million AUD | 104.425% |
| Botanix Pharmaceuticals Limited | -6.55 Million AUD | 100.867% |
| BTC Health Limited | 16.36 Thousand AUD | -247.262% |
| Chimeric Therapeutics Limited | 7.45 Million AUD | 99.238% |
| Clarity Pharmaceuticals Ltd | 11.5 Million AUD | 99.506% |
| Clinuvel Pharmaceuticals Limited | 78.09 Million AUD | 99.927% |
| Biome Australia Limited | 7.66 Million AUD | 99.259% |
| Hexima Limited | - AUD | -Infinity% |
| Immutep Limited | 1.44 Million AUD | 96.065% |
| Memphasys Limited | 1606.00 AUD | -3437.484% |
| Neuren Pharmaceuticals Limited | 205.17 Million AUD | 99.972% |
| Noxopharm Limited | -534.81 Thousand AUD | 110.623% |
| Prescient Therapeutics Limited | 3.71 Million AUD | 98.47% |
| Race Oncology Limited | 1.38 Million AUD | 95.913% |
| Radiopharm Theranostics Limited | -21.3 Million AUD | 100.267% |
| Starpharma Holdings Limited | 7.65 Million AUD | 99.258% |
| Tissue Repair Ltd | 150.51 Thousand AUD | 62.254% |
| Biotron Limited | -40.49 Thousand AUD | 240.283% |
| Alterity Therapeutics Limited | 3.8 Million AUD | 98.507% |
| CSL Limited | 15.28 Billion AUD | 100.0% |
| EZZ Life Science Holdings Limited | 50.94 Million AUD | 99.888% |
| Anatara Lifesciences Ltd | -748.91 Thousand AUD | 107.586% |
| Bio-Gene Technology Limited | -301.44 Thousand AUD | 118.846% |
| Zelira Therapeutics Limited | 10.28 Thousand AUD | -452.431% |
| Patrys Limited | 1.39 Million AUD | 95.925% |
| Orthocell Limited | 3.68 Million AUD | 98.46% |
| Imugene Limited | -5.83 Million AUD | 100.973% |
| PYC Therapeutics Limited | 22.05 Million AUD | 99.742% |
| Proteomics International Laboratories Limited | -1.12 Million AUD | 105.058% |
| Cynata Therapeutics Limited | 2.31 Million AUD | 97.547% |
| Arovella Therapeutics Limited | -25.97 Thousand AUD | 318.684% |
| Nanollose Limited | -348.95 Thousand AUD | 116.281% |
| Invex Therapeutics Ltd | 1.21 Million AUD | 95.314% |
| NeuroScientific Biopharmaceuticals Limited | -91.33 Thousand AUD | 162.2% |
| Amplia Therapeutics Limited | 4.01 Million AUD | 98.584% |
| Island Pharmaceuticals Limited | 1.25 Million AUD | 95.461% |
| Nyrada Inc. | -5164.07 AUD | 1200.14% |
| Telix Pharmaceuticals Limited | 308.5 Million AUD | 99.982% |
| Dimerix Limited | 583.47 Thousand AUD | 90.263% |
| PharmAust Limited | -1641.00 AUD | 3562.035% |
| AnteoTech Limited | 460.39 Thousand AUD | 87.66% |
| Recce Pharmaceuticals Ltd | -366.76 Thousand AUD | 115.49% |
| Avecho Biotechnology Limited | -43.79 Thousand AUD | 229.723% |
| Actinogen Medical Limited | 9.93 Million AUD | 99.428% |
| Immuron Limited | 3.33 Million AUD | 98.297% |
| Argenica Therapeutics Limited | 2.59 Million AUD | 97.813% |